A CRO, or contract research organization, is a company that provides, on a contractual basis, services in the biomedical research field. Given their crucial role in the development of new treatments and technologies, as well as their economic importance, BIOQuébec and CATALIS, with financial support from the Ministry of Economy and Innovation, conducted a study of Quebec CROs to chart the sector’s impact and measure its growth, strengths, and needs.

studyreportGuest UserMay 9, 2023BIOOQuébecinnovation, study report, biopharmaceutical

ONCODESIGN announces the separation of its two business lines – Service and Biotech

ONCODESIGN announces the separation of its two business lines – Service and Biotech – and its entry into exclusive negotiations with Elyan Partners for the sale of a majority stake in ONCODESIGN (Service), followed by a simplified takeover offer

NewsGuest UserJuly 6, 2022ONCODESIGN, biopharmaceutical, separation, biotech

A Framework for Action to Support Quebec’s Biopharmaceutical Innovations and Bolster Quebec’s Autonomy

BIOQuébec commissioned The JBL Group to produce a comprehensive account of the situation by first, rigorously documenting the Quebec healthcare system’s recommendation process for Quebec-based innovations and secondly, to develop, with industry partners, public policy proposals that would support the Quebec biopharmaceutical industry’s innovations and development. BIOQuébec’s review was prompted by a widespread perception among many members that Quebec-based drugs and biopharmaceutical industry products were unfavourably considered by the Quebec health and social services network.

studyreportGuest UserMay 24, 2022BIOOQuébecinnovation, study report, biopharmaceutical

Domain Therapeutics Raises $42m Series A Financing

BigBio Communications, publisher of Big4Bio, the premier aggregator of financial, clinical, and business news from the top life sciences regions, is proud to announce the upcoming launch of “BioStartup News” (biostartup.news), a weekly newsletter recapping the latest developments of U.S.-based life sciences startups.

NewsGuest UserMay 13, 2022Financing, Domain Therapeutic, biopharmaceutical

Bausch + Lomb Corporation Announces Launch of IPO and Roadshow

GE Healthcare will incorporate Imeka's neuroimaging technology into BrainWave MRI to provide additional insights into central nervous system diseases and disorders

NewsGuest UserMay 13, 2022biopharmaceutical, eye health, investment

Theratechnologies to Focus Its Commercialization Activities on the North American Territory

Bromont (Québec), April 21 2022 — BIOQuébec is pleased to be releasing the results of a study on the integration of Quebec innovations into our healthcare system. It is also suggests courses of action to better support Quebec-based biopharmaceutical innovations during the entire process and strengthen Quebec’s autonomy.

NewsGuest UserApril 28, 2022theratechnologies, NorthAmerica, biopharmaceutical

New collaboration to improve the detection of type 2 diabetes in high-risk patients starts in Montreal, Quebec

GE Healthcare will incorporate Imeka's neuroimaging technology into BrainWave MRI to provide additional insights into central nervous system diseases and disorders

NewsGuest UserApril 21, 2022diabetes, AI, biopharmaceutical

nplex-McGill partnership selected by CQDM for a $1M grant to apply next-generation ELISA in drug discovery

McGill University and CQDM announced today that a collaborative project between McGill and nplex biosciences to further develop a highly-scalable protein detection method, termed the “nELISA”, has been selected for funding by CQDM.

NewsGuest UserJuly 23, 2020CQDM, biopharmaceutical, Mesentech, Technology, Drug delivery, bone

CQDM becomes a shareholder of Mesentech to support the validation of a highly promising bone-targeting drug delivery technology

The CQDM is launching its new SynergiQc program, designed to stimulate industrial research in the biopharmaceutical field within academic settings and to create economic benefits for Quebec.

NewsGuest UserJune 22, 2020CQDM, biopharmaceutical, Mesentech, Technology, Drug delivery, bone

3D Printing In The Pharmaceutical Industry — Where Does It Currently Stand?

Not surprisingly, established players continue to invest in 3D-printing research, while newer manufacturers are also breaking into the pharmaceutical space. An article by Jerry Martin.

NewsCatherine LamontagneDecember 21, 2018BIOOQuébec3D printing, biopharmaceutical

CQDM's new SynergiQc program – Financing available for all fields of biopharmaceutical research in Quebec

The CQDM is launching its new SynergiQc program, designed to stimulate industrial research in the biopharmaceutical field within academic settings and to create economic benefits for Quebec.